Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease
BelgiumA Study Testing the Safety of LTX-002 Sodium Given into the Spinal Canal in Adults with Amyotrophic Lateral Sclerosis
GermanyTesting the Safety of Dendritic Cell and CAR-T Cell Combination Therapy in Patients with Newly Diagnosed Diffuse Intrinsic Pontine Glioma
SpainA study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy
BelgiumA study testing ACT-1004-1239 compared to placebo for adults with progressive multiple sclerosis to measure nerve repair using MRI scans
The NetherlandsStudy of Cenegermin Nasal Spray for Safety and Tolerability in Children with Spastic Cerebral Palsy
ItalyTesting 18F-DPA-714 PET scan as a marker of brain inflammation in patients with autoimmune encephalitis
FranceA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
AustriaStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
BelgiumA Study Testing SUL-238 in Patients with Early, Untreated Parkinson's Disease to Assess Effects on Brain Energy Metabolism
The NetherlandsA study using MPPF imaging to examine serotonin pathways in the brainstem of patients with Dravet Syndrome epilepsy
FranceA Study Using [AL[18F]F]FAPI-74 PET Scan to Improve Diagnosis and Monitoring of Giant Cell Arteritis in Patients with This Blood Vessel Disease
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
